An exciting programme focussing on the future of OPAT provision across the UK

Chair of the UK OPAT Conference - Prof. Dilip Nathwani OBE
Co-Chairs of the UK OPAT Initiative - Mark Gilchrist & Dr Andrew Seaton

DAY ONE

0930
Welcome and Opening Remarks
Dilip Nathwani - BSAC President
0940
KEYNOTE PRESENTATION - How can OPAT help deliver the NHS Five Year Forward View?
Philip Howard - Leeds Teaching Hospitals NHS Trust

PLENARY SESSION: Clinical challenges in OPAT
Chair: Dilip Nathwani, OBE, BSAC President
1010
Endocarditis
Jonathan Sandoe - Leeds General Infirmary
1030
Spinal Infections
Neil Ritchie, Glasgow
1050
Paediatrics - a special population?
Sanjay Patel - Southampton Children's Hospital

1115
REFRESHMENTS AND NETWORKING

PLENARY SESSION: Invited papers selected from abstracts
Chair: Andrew Seaton, Glasgow
1145
Clinical efficacy, cost-analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield OPAT service
Chris Durojaye, Royal Hallamshire Hospital, Sheffield
1200
A re- audit evaluating the management of OPAT bronchiectasis patients against current BTS guidelines
Heather Boniface, Paediatrics, Princess Royal Hospital, Telford
1215
Success of an outpatient parenteral antimicrobial therapy (OPAT) programme in a large UK paediatric hospital
David Porter, Alder Hey NHS Trust, Liverpool
1230
Self-administration of intravenous antibiotics for OPAT
Emma Nickerson, Nottingham University Hospitals NHS Trust

1245
LUNCH, POSTER VIEWING

1400
SPONSORED SESSION - Cardiome - "Dalbavancin - The data, the patients and the practical considerations"
Chair: Dilip Nathwani - BSAC President

WORKSHOPS
Chair:
Workshop one: Treatment of skin and soft tissue infections in the ambulatory setting - the Nottingham experience
Chair: Elizabeth Hart, Infectious Disease and Acute Medicine Physician, Nottingham Univerisity Hospitals Trust
1445
Learning outcome: Examining how to choose the right agent in the ambulatory care setting, including a review of licensed agents and drivers for prescribing - cost versus convenience versus stewardship versus stability.
Susan Snape, Consultant Microbiologist, Sarah Williams, Specialist Nurse, Tim Hills, OPAT PHarmacist, Elizabeth Hart, Infectious Disease and Acute Medicine Physician - Nottingham University Hospitals
Workshop two: Community initiated OPAT services - Admission Avoidance
Chair: Chair: Sharon Bamber and John Cunniffe, Wirral University Teaching Hospital
1445
Learning outcomes: Examining key factors in establishing admission avoidance services through safe, competency led services and appropriate patient selection
Sharon Bamber and John Cunniffe - Wirral University Teaching Hospital

1545
REFRESHMENTS AND POSTER VIEWING

PARALLEL SESSIONS
Chair:
Session one: The challenges of IV and oral therapies in the OPAT setting
Chair: Mark Gilchrist - Imperial College Healthcare NHS Trust
1615
IVOST: principles and practice in OPAT
Andrew Seaton, NHS Greater Glasgow and Clyde
1635
Oral Versus Intra-venous Antibiotic Treatment for Bone and Joint Infections
Matthew Scarborough - Oxford University Hospitals NHS Trust
1655
Resurgence of older oral therapies in OPAT
Carolyn Hemsley, Guy's and St Thomas's Hospital, London
1715
Panel discussion
Session Two: Managing Vascular Access - facilitated by IVTEAM
Chair: Andrew Jackson - The Rotherham NHS Foundation Trust
1615
Introduction: Tip location, CLABSI, Midlines and Passports
Andrew Jackson, IV Nurse Consultant, The Rotherham NHS Foundation Trust and Director IVTEAM
1620
Infection Prevention and Vascular Access
Martin Kiernan, ‎Visiting Clinical Fellow, University of West London - ‎GAMA Healthcare
1635
Vessel Health and Preservation Framework
Tim Jackson, ‎Consultant Anaesthetist & Intensivist at Calderdale & Huddersfield NHS Foundation Trust
1655
ECG PICC Tip Location
Gemma Oliver, Nurse Consultant Integrated IV Care at East Kent Hospitals University NHS Foundation Trust
1715
Panel Discussion

1730
WELCOME DRINKS AND NETWORKING

DAY TWO

0730
Breakfast / Coffee / Tea / Bagel
CLINICAL LESSONS: Invited papers selected from abstracts
Chair: Mark Gilchrist - Imperial College Healthcare NHS Trust, London
0800
Clinical efficacy of daily parenteral infusions of meropenem and ampicillin in the OPAT setting
James Pollard, Hospital in the Home, Victoria, Australia
0815
Endocarditis
Jonathan Sandoe, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds
0830
A Case of Unintended Consequences –lessons to be learned
Beth White, Queen Elizabeth University Hospital, Glasgow
0845
Staphylococcus aureus Bacteraemia & optimal OPAT management - doing the right thing isn't always easy!
Eoghan de Barra, Imperial College Healthcare Trust, London

PLENARY SESSION: Antimicrobial Stewardship and OPAT: Special populations
Chair: Andrew Seaton, Queen Elizabeth University Hospital, Glasgow
0900
Treating MDR Negatives in OPAT
Fiona Robb, Antimicrobial Pharmacist, NHS Greater Glasgow and Clyde
0925
Paediatric OPAT: an Australasian approach
Penelope Bryant - Australasian Paediatric Antimicrobial Stewardship Group
0950
Q&A

PARALLEL SESSIONS
Chair:
Session One: Financial considerations in securing and extending OPAT services
Chair: Sanjay Patel - Southampton Children's Hospital
1000
Proving cost effectiveness in OPAT - what a commissioner needs to know
Sue Snape - Nottingham University Hospitals
1025
Funding pathways for OPAT
Achyut Guleri, Blackpool
1050
Q&A
Session Two: Establishing a National Nurses OPAT Forum: Lessons from a regional service
Chair: Carole Fry, Public Health England, London
1000
Interactive session to discuss practical nursing aspects to OPAT
Kate Owen - The Dudley Group NHS Foundation Trust and Gemma Oliver, East Kent Hospital University Trust, Kent

1100
REFRESHMENTS AND POSTER VIEWING

1130
SPONSORED SYMPOSIUM - Baxter Healthcare Ltd - "Driving Efficiency in Pathway Design through Patient Self-Administration"
Ann Cole - Baxter Healthcare Ltd

PLENARY SESSION: Research, policy and data - driving the clinical and nursing agenda
Chair: Andrew Seaton, Queen Elizabeth Hospital Trust, Glasgow and Mark Gilchrist, Imperial College Healthcare Trust, London
1215
NIHR Summary of OPAT work
Jane Minton - Leeds Teaching Hospitals
1235
Revised EPIC3 guidelines impact on OPAT
Kate Owen - The Dudley Group NHS Foundation Trust
1255
Drug stability - why open access publication of stability data is essential
Mark Santillo - Torbay & South Devon NHS Trust
1315
Panel discussion

1340
CLOSING REMARKS - Where next for the OPAT in the UK?
Mark Gilchrist, Imperial College Healthcare Trust, London